Compositions and methods for inhibiting expression of 3-hydroxy-3methylglutaryl-coa reductase (HMGCR)

PH12025553173A1Pending Publication Date: 2026-09-02SHANGHAI ARGO BIOPHARMACEUTICAL CO LTD
0 Cites 0 Cited by

Patent Information

Application Number
PH12025553173
Authority / Receiving Office
PH · PH
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-12-19
Publication Date
2026-09-02
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.